Factors related to the continuation of aripiprazole once-monthly treatment at 1 year

Asian J Psychiatr. 2018 Jan:31:133-134. doi: 10.1016/j.ajp.2018.02.014. Epub 2018 Feb 12.

Authors

Hidenobu Suzuki¹, Hiroyuki Hibino², Yuichi Inoue³, Atsuhiko Takaya²

Affiliations

¹ Department of Psychiatry, Suzuki Clinic, 3-34-16 Hamadayama, Suginami, Tokyo, 168-0065, Japan. Electronic address: suzuhiromarket@yahoo.co.jp.
² Department of Psychiatry, Fukui Kinen Hospital, Kanagawa 238-0115, Japan.
³ Department of Psychiatry, Shakomae Kokorono Clinic, Tokyo 116-0011, Japan.

PMID: 29486415
DOI: 10.1016/j.ajp.2018.02.014

No abstract available

Publication types

Letter

MeSH terms

Adult
Antipsychotic Agents / therapeutic use*
Aripiprazole / therapeutic use*
Cohort Studies
Drug Administration Schedule
Female
Follow-Up Studies
Humans
Kaplan-Meier Estimate
Male
Patient Compliance / psychology
Patient Compliance / statistics & numerical data*
Retrospective Studies
Schizophrenia / drug therapy*
Treatment Outcome
Withholding Treatment / statistics & numerical data*

Substances

Antipsychotic Agents
Aripiprazole